Ivacaftor hydrate

参考资料仅供科学研究，不可用于个人用途。

货号：BCP14735CAS号：1134822-07-3纯度：98%

在线咨询

购买咨询

全国免运费！免费咨询：400-099-8200 或手机联系：13472751340

* 必填项

请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS号	1134822-07-3	货号	BCP14735
中文名	Ivacaftor hydrate
英文名	Ivacaftor hydrate
中文别名
英文别名	VX-770 hydrate;VX 770 hydrate;VX770 hydrate;Kalydeco hydrate;
SMILES
化学名称
分子式	C24H30N2O4	分子量	410.51
纯度	98%	配送	惯例下常温包邮
产品描述	in vitro: In recombinant cells VX-770 increased CFTR channel open probability (P(o)) in both the F508del processing mutation and the G551D gating mutation. VX-770 also increased Cl(-) secretion in cultured human CF bronchial epithelia (HBE) carrying the G551D gating mutation on one allele and the F508del processing mutation on the other allele by approximately 10-fold, to approximately 50% of that observed in HBE isolated from individuals without CF. in vivo: At day 28, in the group of subjects who received 150 mg of VX-770, the median change in the nasal potential difference (in response to the administration of a chloride-free isoproterenol solution) from baseline was -3.5 mV (range, -8.3 to 0.5; P=0.02 for the within-subject comparison, P=0.13 vs. placebo), and the median change in the level of sweat chloride was -59.5 mmol per liter (range, -66.0 to -19.0; P=0.008 within-subject, P=0.02 vs. placebo). Toxicity: Six severe adverse events occurred in two subjects (diffuse macular rash